Stock Price Movement and Market Context
On 23 Feb 2026, TTK Healthcare opened with a notable gap up of 7.53%, reaching an intraday high of Rs.999. However, the stock reversed course to close at its new 52-week low of Rs.921.15, reflecting a day’s decline of 0.84%. This performance lagged the diversified sector by 1.29%, highlighting the stock’s relative weakness despite a broadly positive market environment. The Sensex, in contrast, advanced by 0.51%, closing at 83,239.92, just 3.51% shy of its 52-week high of 86,159.02. Mega-cap stocks led the market rally, while TTK Healthcare’s shares remained under pressure.
TTK Healthcare’s trading activity today was marked by high volatility, with an intraday weighted average price volatility of 7.54%. The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum.
Long-Term Performance and Financial Metrics
Over the past year, TTK Healthcare’s stock has declined by 25.59%, a stark contrast to the Sensex’s 10.48% gain over the same period. The stock’s 52-week high was Rs.1,402, underscoring the extent of the recent price erosion. This underperformance extends beyond the last year, with the stock lagging the BSE500 index across the last three years, one year, and three months.
Financially, the company has exhibited modest growth, with net sales increasing at an annualised rate of 6.99% and operating profit growing at 15.42% over the last five years. Despite these figures, the company’s overall growth trajectory has been described as subdued, contributing to the cautious market sentiment.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Recent Financial Highlights and Ratios
The company’s half-year financials reveal some concerning trends. Cash and cash equivalents have declined to Rs.600.89 crores, the lowest level recorded in recent periods. The debtors turnover ratio has also dropped to 7.40 times, indicating slower collection efficiency. Additionally, non-operating income constitutes a significant 80.43% of the quarterly profit before tax, suggesting that core business profitability remains limited.
TTK Healthcare maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure. The return on equity (ROE) stands at 6.5%, which, while positive, is modest relative to industry standards. The stock’s price-to-book value ratio is 1.2, indicating an attractive valuation on a book value basis, though it trades at a premium compared to its peers’ historical averages.
Market Participation and Shareholding
Despite the company’s size, domestic mutual funds hold a minimal stake of just 0.01%. Given that mutual funds typically conduct thorough research and due diligence, this limited exposure may reflect a cautious stance on the stock’s prospects or valuation at current levels.
Valuation and Profitability Trends
While the stock has generated a negative return of 25.59% over the past year, the company’s profits have increased marginally by 2.4% during the same period. The price/earnings to growth (PEG) ratio is notably high at 8, suggesting that the stock’s price does not align favourably with its earnings growth rate.
Holding TTK Healthcare Ltd. from Diversified? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Mojo Score and Rating Update
TTK Healthcare’s current Mojo Score stands at 37.0, with a Mojo Grade of Sell, downgraded from Hold on 21 Jul 2025. The market capitalisation grade is rated at 4, reflecting the company’s mid-tier size within the diversified sector. This downgrade aligns with the stock’s recent price performance and financial metrics.
Summary of Key Concerns
The stock’s decline to Rs.921.15, its lowest level in 52 weeks, is underpinned by a combination of factors including subdued long-term growth rates, limited profit expansion, and a high PEG ratio. The reliance on non-operating income for a substantial portion of quarterly profits raises questions about the sustainability of earnings. Furthermore, the low participation by domestic mutual funds and the stock’s trading below all major moving averages indicate a cautious market outlook.
Market Environment and Sector Comparison
While the broader market and mega-cap stocks have shown resilience and gains, TTK Healthcare’s performance contrasts sharply with these trends. The Sensex’s proximity to its 52-week high and positive momentum in the diversified sector underscore the stock’s relative weakness. This divergence highlights the challenges faced by TTK Healthcare in maintaining investor confidence and market relevance.
Conclusion
TTK Healthcare Ltd.’s stock reaching a 52-week low of Rs.921.15 reflects ongoing challenges in achieving robust growth and profitability. The company’s financial indicators and market positioning suggest a cautious stance among investors, as evidenced by the recent downgrade to a Sell rating and the stock’s underperformance relative to benchmarks. The current valuation metrics and trading patterns provide a comprehensive picture of the stock’s status within the diversified sector.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
